Literature DB >> 8503878

Photoaffinity labelling of smooth-muscle myosin by methylanthraniloyl-8-azido-ATP.

S Maruta1, M Ikebe.   

Abstract

Methylanthraniloyl-8-azido-ATP (Mant-8-N3-ATP), which binds to the 20 kDa C-terminal tryptic fragment of skeletal-muscle myosin subfragment-1 [Maruta, Miyanishi and Matsuda (1989) Eur. J. Biochem. 184, 213-221], was synthesized and used as a probe of the conformational change of smooth-muscle myosin. Mant-8-N3-ATP, like ATP, induced the formation of the 10 S conformation at low ionic strength. In the presence of vanadate, smooth-muscle myosin formed a stable complex with Mant-8-N3-ADP, and this complex showed the 10 S-->6 S transition of myosin. ATP-binding sites for 6 S (extended state) and 10 S (folded state) myosin were studied by photolabelling of myosin with Mant-8-N3-ADP. For both 6 S and 10 S myosin, Mant-8-N3-ATP was incorporated into the 29 kDa N-terminal tryptic fragment of myosin heavy chain. This is unlike the labelling of skeletal-muscle myosin, in which the 20 kDa C-terminal fragment is labelled. The labelling of 29 kDa fragment was diminished significantly by addition of ATP. These results suggest that the conformation of the ATP-binding site of smooth-muscle myosin is different from that of skeletal-muscle myosin. To examine further the possible differences in the labelling site between 6 S and 10 S myosin, the affinity-labelled 29 kDa fragment was subjected to complete proteolysis by lysylendo-peptidase. The fluorescent-labelled-peptide map suggested that the Mant-8-N3-ADP-binding sites for 6 S and 10 S myosin were identical.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503878      PMCID: PMC1134228          DOI: 10.1042/bj2920439

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Inhibition of myosin ATPase by vanadate ion.

Authors:  C C Goodno
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

2.  Interaction between actomyosin and 8-substituted ATP analogs.

Authors:  H Takenaka; M Ikehara; Y Tonomura
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

3.  The conformation of adenosine diphosphoribose and 8-bromoadenosine diphosphoribose when bound to liver alcohol dehydrogenase.

Authors:  M A Abdallah; J F Biellmann; B Nordström; C I Brändén
Journal:  Eur J Biochem       Date:  1975-01-15

4.  Electron microscopic studies of myosin molecules from chicken gizzard muscle II: The effect of thiophosphorylation of the 20K-dalton light chain on the ATP-induced change in the conformation of myosin monomers.

Authors:  H Onishi; T Wakabayashi; T Kamata; S Watanabe
Journal:  J Biochem       Date:  1983-10       Impact factor: 3.387

5.  Myosin filaments have non-phosphorylated light chains in relaxed smooth muscle.

Authors:  A V Somlyo; T M Butler; M Bond; A P Somlyo
Journal:  Nature       Date:  1981-12-10       Impact factor: 49.962

6.  Light-chain phosphorylation controls the conformation of vertebrate non-muscle and smooth muscle myosin molecules.

Authors:  R Craig; R Smith; J Kendrick-Jones
Journal:  Nature       Date:  1983 Mar 31-Apr 6       Impact factor: 49.962

7.  Electron microscopic studies of myosin molecules from chicken gizzard muscle I: the formation of the intramolecular loop in the myosin tail.

Authors:  H Onishi; T Wakabayashi
Journal:  J Biochem       Date:  1982-09       Impact factor: 3.387

8.  Adenosine triphosphate-induced reversible change in the conformation of chicken gizzard myosin and heavy meromyosin.

Authors:  H Suzuki; T Kamata; H Onishi; S Watanabe
Journal:  J Biochem       Date:  1982-05       Impact factor: 3.387

9.  A bent monomeric conformation of myosin from smooth muscle.

Authors:  K M Trybus; T W Huiatt; S Lowey
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

10.  Correlation of enzymatic properties and conformation of smooth muscle myosin.

Authors:  M Ikebe; S Hinkins; D J Hartshorne
Journal:  Biochemistry       Date:  1983-09-13       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.